The CAR-TCR Summit celebrates 5 years of bringing together the world’s leaders in innovating, developing and delivering CAR and TCR based immunotherapies to patients globally with a mission to ENGINEER A CANCER FREE WORLD.
The CAR-TCR Summit is world renowned for providing industry leaders with the most up-to-date and comprehensive insight into the full end-to-end drug development chain as well as never-seen-before data from the movers and shakers in the CAR-TCR landscape including Adaptimmune, Endocyte, Celyad, Allogene and many more!
This year, bringing together over 1000 industry leaders, the CAR-TCR Summit is the only meeting you need to attend with:
- 15 Engaging, Discussion-Based Strategic Dives; exploring your biggest challenges and creating tangible actions to advance your pipeline
- 6 End-to-End Tracks; analyzing effective strategies from discovery through to commercialization
- 3 Focus Day Agendas; dedicated to key topics: targeting solid tumors, overcoming manufacturing bottlenecks with novel gene editing platforms, and advancing TCR drug development to match the success of CAR-T
Take advantage of this unrivalled learning and networking opportunity across 4 days packed with content and dedicated interactive formats to ensure you leave equipped with the connections and takeaways you need to develop a targeted, efficacious and accessible CAR or TCR product to cure patients in need around the world.
"The CAR-TCR summit is an ideal size and attracts the key players in the field. Good opportunity for networking and getting the relevant updates about progress in the space."
"This meeting is increasingly becoming the venue for significant breaking news in the field"
"This is a best in class and top summit in the CAR-TCR area which is an invaluable asset to both industry and academia"
University of Pennsylvania